What is Compass Pathways Plc's earnings per share (EPS)?

Compass Pathways Plc (CMPS) reported diluted earnings per share of $-3.08 for fiscal year 2025. This represents a -33.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Compass Pathways Plc Financials

CMPS

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Compass Pathways Plc (CMPS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CMPS FY2025 2026-05-13

Clinical-development spending is being funded by repeated external capital raises, while the balance sheet shifted to negative equity.

From FY2024 to FY2025, operating loss barely changed at about -$179.0M, yet net loss widened to -$269.8M and operating cash outflow deepened to -$157.2M. Because financing supplied $140.7M in the same year, the company preserved cash by raising capital rather than by improving cash conversion, which is why liquidity looked better than the income statement alone would suggest.

The cost structure is overwhelmingly program spending: FY2025 R&D of $118.4M was nearly twice SG&A of $60.6M, while capital spending has been close to zero for three years. That means most cash use is expensed immediately into research and administration instead of turning into long-lived operating assets.

The balance sheet has tightened quickly. Current assets of $191.5M no longer covered current liabilities of $247.8M in FY2025, versus a large cushion in FY2023, and shares outstanding climbed from 61.9M to 96.1M over that span. The business is still finding funding, but each refill has come with a weaker ownership base and less balance-sheet flexibility.

Financial Health Signals

Financial health score pending refresh

We are recalculating Compass Pathways Plc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

2/7

Compass Pathways Plc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.58x

For every $1 of reported earnings, Compass Pathways Plc generates $0.58 in operating cash flow (-$157.2M OCF vs -$269.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-39.8x

Compass Pathways Plc earns $-39.8 in operating income for every $1 of interest expense (-$179.0M vs $4.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$178.8M

YoY-0.5%

Compass Pathways Plc's EBITDA was -$178.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 0.5% from the prior year.

Net Income

-$269.8M

YoY-73.9%

Compass Pathways Plc reported -$269.8M in net income in fiscal year 2025. This represents a decrease of 73.9% from the prior year.

EPS (Diluted)

$-3.08

YoY-33.9%

Compass Pathways Plc earned $-3.08 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 33.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$149.6M

YoY-9.4%

5Y CAGR-4.7%

Compass Pathways Plc held $149.6M in cash against $14.1M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

96M

YoY+40.2%

5Y CAGR+21.7%

Compass Pathways Plc had 96M shares outstanding in fiscal year 2025. This represents an increase of 40.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$118.4M

YoY-0.5%

5Y CAGR+38.4%

Compass Pathways Plc invested $118.4M in research and development in fiscal year 2025. This represents a decrease of 0.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

CMPS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$118.4M-0.5%	$119.0M+36.0%	$87.5M+34.5%	$65.1M+47.8%	$44.0M+88.4%	$23.4M
SG&A Expenses	$60.6M+2.4%	$59.2M+19.8%	$49.4M+8.9%	$45.4M+15.7%	$39.2M+39.8%	$28.0M
Operating Income	-$179.0M-0.5%	-$178.2M-30.2%	-$136.9M-24.0%	-$110.4M-32.7%	-$83.2M-61.9%	-$51.4M
Interest Expense	$4.5M0.0%	$4.5M+104.2%	$2.2M	$0	$0	N/A
Income Tax	-$2.5M-255.1%	$1.6M+104.4%	$780K+91.2%	$408K+105.0%	$199K+521.9%	$32K
Net Income	-$269.8M-73.9%	-$155.1M-30.9%	-$118.5M-29.5%	-$91.5M-27.5%	-$71.7M-18.9%	-$60.3M
EPS (Diluted)	$-3.08-33.9%	$-2.30+0.9%	$-2.32-7.4%	$-2.16-20.7%	$-1.79+49.6%	$-3.55

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$26.5M	N/A	$27.3M-9.9%	$30.3M-1.8%	$30.9M	N/A	$32.9M+13.3%	$29.1M
SG&A Expenses	$16.4M	N/A	$13.2M+4.8%	$12.6M-32.7%	$18.7M	N/A	$15.0M+5.0%	$14.3M
Operating Income	-$42.9M	N/A	-$40.5M+5.6%	-$42.9M+13.5%	-$49.6M	N/A	-$47.9M-10.6%	-$43.3M
Interest Expense	$1.5M	N/A	$1.1M-4.0%	$1.2M+27.9%	$900K	N/A	$1.1M+2.2%	$1.1M
Income Tax	-$11K	N/A	-$230K-267.9%	$137K-61.3%	$354K	N/A	$173K-1.7%	$176K
Net Income	$91.2M	N/A	-$137.7M-258.6%	-$38.4M-115.0%	-$17.9M	N/A	-$38.5M-1.1%	-$38.1M
EPS (Diluted)	$-0.30	N/A	$-1.44-251.2%	$-0.41-70.8%	$-0.24	N/A	$-0.560.0%	$-0.56

CMPS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$210.3M-1.6%	$213.7M-22.6%	$276.0M+39.9%	$197.3M-34.4%	$300.9M+47.9%	$203.5M
Current Assets	$191.5M-4.9%	$201.3M-23.0%	$261.3M+36.3%	$191.7M-35.1%	$295.3M+45.9%	$202.4M
Cash & Equivalents	$149.6M-9.4%	$165.1M-25.0%	$220.2M+53.8%	$143.2M-47.6%	$273.2M+43.6%	$190.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$263.2M+346.3%	$59.0M+17.4%	$50.2M+213.7%	$16.0M-2.9%	$16.5M+139.1%	$6.9M
Current Liabilities	$247.8M+628.5%	$34.0M+73.5%	$19.6M+25.7%	$15.6M+3.2%	$15.1M+119.1%	$6.9M
Long-Term Debt	$14.1M-42.8%	$24.7M-14.3%	$28.8M	$0	N/A	N/A
Total Equity	-$52.8M-134.2%	$154.7M-31.5%	$225.7M+24.5%	$181.3M-36.3%	$284.4M+44.7%	$196.6M
Retained Earnings	-$822.6M-53.8%	-$534.7M-40.9%	-$379.6M-45.4%	-$261.1M-53.9%	-$169.6M-73.3%	-$97.9M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$531.7M+152.8%	$210.3M-17.7%	$255.6M-12.9%	$293.5M-8.0%	$319.1M+49.4%	$213.7M-13.6%	$247.3M-11.2%	$278.5M
Current Assets	$510.9M+166.8%	$191.5M-21.0%	$242.4M-12.3%	$276.4M-9.5%	$305.5M+51.8%	$201.3M-13.9%	$233.7M-11.9%	$265.1M
Cash & Equivalents	$466.0M+211.5%	$149.6M-19.5%	$185.9M-16.2%	$221.9M-14.7%	$260.1M+57.6%	$165.1M-20.2%	$207.0M-9.5%	$228.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$205.1M-22.1%	$263.2M+20.7%	$218.0M+66.4%	$131.0M+5.9%	$123.7M+109.7%	$59.0M+8.6%	$54.3M+3.9%	$52.3M
Current Liabilities	$153.8M-37.9%	$247.8M+25.5%	$197.4M+530.3%	$31.3M+4.4%	$30.0M-11.8%	$34.0M+29.8%	$26.2M+19.0%	$22.0M
Long-Term Debt	$50.5M+257.7%	$14.1M-24.1%	$18.6M-19.0%	$23.0M+6.5%	$21.6M-12.6%	$24.7M-10.8%	$27.6M-6.1%	$29.4M
Total Equity	$326.7M+718.2%	-$52.8M-240.6%	$37.6M-76.9%	$162.6M-16.8%	$195.5M+26.4%	$154.7M-19.9%	$193.0M-14.7%	$226.3M
Retained Earnings	-$731.4M+11.1%	-$822.6M-12.9%	-$728.7M-23.3%	-$591.0M-6.9%	-$552.6M-3.3%	-$534.7M-8.8%	-$491.4M-8.5%	-$452.9M

CMPS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$157.2M-31.9%	-$119.2M-22.4%	-$97.4M+7.7%	-$105.5M-55.7%	-$67.7M-63.7%	-$41.4M
Capital Expenditures	N/A	$0-100.0%	$66K-88.9%	$596K+78.4%	$334K+155.0%	$131K
Free Cash Flow	N/A	-$119.2M-22.3%	-$97.4M+8.1%	-$106.0M-55.8%	-$68.1M-64.0%	-$41.5M
Investing Cash Flow	N/A	$0+100.0%	-$64K+89.3%	-$596K-78.4%	-$334K+46.8%	-$628K
Financing Cash Flow	$140.7M+120.5%	$63.8M-63.3%	$173.8M+16614.4%	$1.0M-99.3%	$156.6M-19.3%	$194.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$47.9M-26.9%	-$37.8M-7.6%	-$35.1M+9.3%	-$38.7M+15.3%	-$45.7M-9.3%	-$41.8M-88.2%	-$22.2M+35.5%	-$34.4M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$0	$0	$0
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$41.8M-88.2%	-$22.2M+35.5%	-$34.4M
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0	$0	$0
Financing Cash Flow	$362.5M+193725.7%	$187K	$0-100.0%	$166K-99.9%	$140.4M+90454.2%	$155K+392.5%	-$53K-125.2%	$210K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CMPS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	-100.3%-47.8pp	-52.5%-2.0pp	-50.5%-25.3pp	-25.2%+5.5pp	-30.7%
Return on Assets	-128.3%-55.6pp	-72.6%-29.7pp	-42.9%+3.5pp	-46.4%-22.5pp	-23.8%+5.8pp	-29.6%
Current Ratio	0.77-5.1	5.92-7.4	13.33+1.0	12.29-7.3	19.55-9.8	29.36
Debt-to-Equity	-0.27-0.4	0.16+0.0	0.13+0.1	0.00-0.1	0.06+0.0	0.04
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	27.9%	N/A	-366.4%-342.7pp	-23.6%-14.5pp	-9.1%	N/A	-20.0%-3.1pp	-16.8%
Return on Assets	17.2%	N/A	-53.9%-40.8pp	-13.1%-7.5pp	-5.6%	N/A	-15.6%-1.9pp	-13.7%
Current Ratio	3.32+2.5	0.77-0.5	1.23-7.6	8.82-1.4	10.18+4.3	5.92-3.0	8.91-3.1	12.03
Debt-to-Equity	0.15+0.4	-0.27-0.8	0.49+0.4	0.14+0.0	0.11-0.0	0.16+0.0	0.14+0.0	0.13
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$52.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.77), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Nutex Health Inc NUTX

$1.1B

Sonida Senior Living Inc SNDA

$1.9B

AUNA S.A. AUNA

$371.8M

Agilon Health Inc AGL

$2.0B

Enhabit EHAB

$706.9M

Frequently Asked Questions

Is Compass Pathways Plc profitable?

No, Compass Pathways Plc (CMPS) reported a net income of -$269.8M in fiscal year 2025.

What is Compass Pathways Plc's EBITDA?

Compass Pathways Plc (CMPS) had EBITDA of -$178.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Compass Pathways Plc have?

As of fiscal year 2025, Compass Pathways Plc (CMPS) had $149.6M in cash and equivalents against $14.1M in long-term debt.

What is Compass Pathways Plc's operating cash flow?

Compass Pathways Plc (CMPS) generated -$157.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Compass Pathways Plc's total assets?

Compass Pathways Plc (CMPS) had $210.3M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Compass Pathways Plc spend on research and development?

Compass Pathways Plc (CMPS) invested $118.4M in research and development during fiscal year 2025.

How many shares does Compass Pathways Plc have outstanding?

Compass Pathways Plc (CMPS) had 96M shares outstanding as of fiscal year 2025.

What is Compass Pathways Plc's current ratio?

Compass Pathways Plc (CMPS) had a current ratio of 0.77 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Compass Pathways Plc's debt-to-equity ratio?

Compass Pathways Plc (CMPS) had a debt-to-equity ratio of -0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Compass Pathways Plc's return on assets (ROA)?

Compass Pathways Plc (CMPS) had a return on assets of -128.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Compass Pathways Plc's cash runway?

Based on fiscal year 2025 data, Compass Pathways Plc (CMPS) had $149.6M in cash against an annual operating cash burn of $157.2M. This gives an estimated cash runway of approximately 11 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Compass Pathways Plc's debt-to-equity ratio negative or unusual?

Compass Pathways Plc (CMPS) has negative shareholder equity of -$52.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Compass Pathways Plc's Piotroski F-Score?

Compass Pathways Plc (CMPS) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Compass Pathways Plc's earnings high quality?

Compass Pathways Plc (CMPS) has an earnings quality ratio of 0.58x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Compass Pathways Plc cover its interest payments?

Compass Pathways Plc (CMPS) has an interest coverage ratio of -39.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.